Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
SHILPAMED.NSthis companyShilpa Medicare Limited	₹933.85	28.05×	2.63×	4.43×	17.12×	-128.2%	40.5%	20.5%	15.8%	9.4%	7.8%	-1.1%	0.25×	1.42×	5.36×	1.31×	0.1%	5	—	2	C
AJANTPHARM.NSAjanta Pharma Limited	₹3,344.00	33.18×	7.74×	6.43×	22.46×	64.5%	51.4%	24.3%	19.4%	23.3%	20.5%	0.4%	0.06×	0.1×	82.23×	2.64×	1.0%	5	18.51	4	A
APLLTD.NSAlembic Pharmaceuticals Limited	₹1,017.30	19.32×	2.3×	1.77×	12.9×	3.1%	45.1%	10.9%	9.2%	11.9%	10.4%	2.0%	0.25×	1.11×	8.54×	1.76×	1.7%	4	—	2	B-
DRREDDY.NSDr. Reddy's Laboratories Limited	₹1,385.00	24.38×	2.77×	3.11×	14.13×	25.1%	52.8%	13.8%	12.8%	11.4%	7.5%	2.9%	0.24×	0.94×	12.42×	1.8×	0.6%	7	5.66	3	B+
GLAND.NSGland Pharma Limited	₹3,302.40	27.2×	2.7×	4.35×	12.94×	-57.3%	30.0%	18.8%	16.0%	9.9%	7.6%	2.6%	0.03×	-1.6×	36.24×	4.68×	1.1%	5	—	2	C+
GRANULES.NSGranules India Limited	₹799.20	25.35×	2.97×	2.81×	13.13×	-42.2%	43.0%	16.6%	11.1%	11.7%	10.1%	0.8%	0.3×	0.52×	7.77×	1.8×	0.2%	5	—	2	C+
Peer median	—	25.35×	2.77×	3.11×	13.13×	3.1%	45.1%	16.6%	12.8%	11.7%	10.1%	2.0%	0.24×	0.52×	12.42×	1.8×	1.0%	5	12.09	2	—